Area served Worldwide Founder Thomas Grogan Founded June 1985 | Industry Medical Services Clinical laboratory Number of employees 1,500 Parent organization Roche Holding AG | |
![]() | ||
Products Medical equipmentAssay development Subsidiaries Spring Bioscience, Inc. Profiles |
Ventana medical systems an office that s a work of art
Ventana Medical Systems, Inc. is a global leader in tissue diagnostics. The company develops, manufactures, and markets instrument reagent systems that automate tissue and slide staining in anatomic pathology laboratories. These products assist in the diagnosis and treatment of cancer and infectious diseases.
Contents
- Ventana medical systems an office that s a work of art
- Ventana medical systems 2014 ame manufacturing excellence award recipient
- Company history
- Key people
- Products
- Company profile
- References
Part of the Roche Diagnostics Division, Ventana is a member of the Roche Group.
Ventana medical systems 2014 ame manufacturing excellence award recipient
Company history
Pathologist and University of Arizona professor Thomas Grogan, M.D., founded Ventana in 1985. The company launched its first instrument reagent system in 1991, and held an Initial Public Offering (IPO) in 1996, trading under the symbol VMSI on the NASDAQ stock exchange.
In 2007, Ventana acquired Spring BioScience Corp, a developer and supplier of monoclonal antibodies. That same year, Ventana rejected a hostile takeover bid from Roche Holding AG for $75 a share. In February 2008, Roche acquired Ventana with a cash offer of $89.50 per share ($3.4 billion).
Key people
Products
Ventana manufactures products within eight areas: